Veranova’s subsidiary, Macfarlan Smith, announced a proposal to close its Annan, UK facility.
Over the last several months, Veranova conducted a review of its manufacturing capacity relative to customer needs and market trends across its product portfolio.
As an outcome of this review, Veranova’s subsidiary, Macfarlan Smith, announced a proposal to close its Annan, UK facility. Macfarlan Smith recognizes the impact this proposal will have on staff at the Annan facility.
Niek Stapel, Veranova’s CEO said “Every effort has been made to avoid proposing the closure of the plant. This was a difficult decision to make which in no way reflects the performance or commitment of our colleagues at Annan.”
The proposed closure is subject to statutory consultation requirements under UK law.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!